e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Novel therapeutic targets and disease markers in pulmonary pathology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Positional cloning on 19q13 identifies
UPAR
as a potential asthma susceptibility gene
C. Browning, S. Barton, S. Bainbridge, S. Mutch, M. Rose-zerilli, A. Wheatley, I. Hall, S. Holgate, P. Tighe, J. Holloway, I. Sayers (Nottingham, Southampton, United Kingdom)
Source:
Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Session:
Novel therapeutic targets and disease markers in pulmonary pathology
Session type:
Oral Presentation
Number:
403
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Browning, S. Barton, S. Bainbridge, S. Mutch, M. Rose-zerilli, A. Wheatley, I. Hall, S. Holgate, P. Tighe, J. Holloway, I. Sayers (Nottingham, Southampton, United Kingdom). Positional cloning on 19q13 identifies
UPAR
as a potential asthma susceptibility gene. Eur Respir J 2007; 30: Suppl. 51, 403
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Investigation for candidate genes of glucocorticoid resistance by genome-wide gene expression profiling in animal model of asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Identification of multiple asthma susceptibility loci within the
lmr1
locus on mouse chromosome 17
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Genetic analysis of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011
Candidate surrogate markers for COPD identified by differential gene expression
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
Involvement of RANTES gene promoter polymorphisms in the susceptibility for childhood asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 694s
Year: 2005
Polymorphism screening of the TBX21 gene and association studies with atopic diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 579s
Year: 2003
Novel polymorphisms in the T-bet gene are associated with childhood asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 135s
Year: 2004
Identification and analysis of rare and novel mutations of the alpha-1-antitrypsin gene
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Characterisation and mRNA expression analysis of the bronchial hyperresponsiveness susceptibility gene protocadherin-1 in asthma patients
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Gene–gene interaction among polymorphisms of
Eotaxin
gene family in Korean asthmatics
Source: Eur Respir J 2005; 26: Suppl. 49, 263s
Year: 2005
Protective effect of intronic polymorphism rs324011 of STAT6 gene on asthma severity
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Linkage and haplotype analyses for chemokine receptors clustered in chromosome 3q21.3 in family pedigrees with asthma and atopy
Source: Eur Respir J 2004; 24: Suppl. 48, 135s
Year: 2004
COPD susceptibility gene on chromosome 4q31 is also associated with lung cancer
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Human exome analysis of candidate genetic variants for susceptibility to high-altitude pulmonary edema in Japanese
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Human genetic variability and susceptibility to pulmonary TB
Source: Eur Respir Mon 2012; 58: 38-58
Year: 2012
Genetic polymorphism of
FOXP3
gene in sarcoidosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006
Investigating the role of IREB2 genetic variants in susceptibility to COPD
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012
Gene expression profiling: identifying novel gene targets for therapeutic intervention
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
Microarray gene expression profiling in a murine model of asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept